Amcor completes sale of BCNA joint venture interest for $122 million
Fiscal 2024 total sales for the joint venture were approximately $190 million
Fiscal 2024 total sales for the joint venture were approximately $190 million
Expects to unlock further opportunities in the Moldovan market, contributing anticipated sales of $300,000 in 2025 and approximately $700,000–$800,000 in 2026
Immedica to commence a cash tender offer to acquire all issued and outstanding shares of Marinus for an enterprise value of approximately US$ 151 million
Both units of Shilpa Medicare (Unit IV and Unit VII), have now received GMP approval from Eurasia
Zydus Lifesciences and SBL have mutually decided to extend the date of closing upto March 31, 2025
The company will receive an upfront payment of Euro 100 million (Rs. 880 crores) for product development and site approval from European authorities
Divestment is part of BASF’s strategic portfolio optimization
The company has received the GMP Certification after successful closure of the inspection
The TGA approval marks a pivotal step in Rusan Pharma’s expansion into the Australian market
Final decision from the European Commission is anticipated within the coming months
Subscribe To Our Newsletter & Stay Updated